Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2011 1
2016 1
2017 1
2019 1
2020 1
2021 2
2022 6
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Genetic Testing Guidelines Impact Care in Newborns with Congenital Heart Defects.
Durbin MD, Fairman K, Helvaty LR, Huang M, Li M, Abreu D, Geddes GC, Helm BM, Landis BJ, McEntire A, Mitchell DK, Ware SM. Durbin MD, et al. Among authors: abreu d. J Pediatr. 2023 Sep;260:113495. doi: 10.1016/j.jpeds.2023.113495. Epub 2023 May 20. J Pediatr. 2023. PMID: 37211210 Free PMC article.
Conformational stability of SARS-CoV-2 glycoprotein spike variants.
Arruda HRS, Lima TM, Alvim RGF, Victorio FBA, Abreu DPB, Marsili FF, Cruz KD, Marques MA, Sosa-Acosta P, Quinones-Vega M, de S Guedes J, Nogueira FCS, Silva JL, Castilho LR, de Oliveira GAP. Arruda HRS, et al. Among authors: abreu dpb. iScience. 2023 Jan 20;26(1):105696. doi: 10.1016/j.isci.2022.105696. Epub 2022 Nov 30. iScience. 2023. PMID: 36465857 Free PMC article.
High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
Gomes SMR, Brito ACS, Manfro WFP, Ribeiro-Alves M, Ribeiro RSA, da Cal MS, Lisboa VDC, Abreu DPB, Castilho LDR, Porto LCMS, Mafort TT, Lopes AJ, da Silva SAG, Dutra PML, Rodrigues LS. Gomes SMR, et al. Among authors: abreu dpb. PLoS One. 2023 Apr 5;18(4):e0283983. doi: 10.1371/journal.pone.0283983. eCollection 2023. PLoS One. 2023. PMID: 37018291 Free PMC article.
From the Approach to the Concept: One Health in Latin America-Experiences and Perspectives in Brazil, Chile, and Colombia.
Pettan-Brewer C, Martins AF, de Abreu DPB, Brandão APD, Barbosa DS, Figueroa DP, Cediel N, Kahn LH, Brandespim DF, Velásquez JCC, Carvalho AAB, Takayanagui AMM, Galhardo JA, Maia-Filho LFA, Pimpão CT, Vicente CR, Biondo AW. Pettan-Brewer C, et al. Among authors: de abreu dpb. Front Public Health. 2021 Sep 14;9:687110. doi: 10.3389/fpubh.2021.687110. eCollection 2021. Front Public Health. 2021. PMID: 34631640 Free PMC article. Review.
Podcasting: contemporary patient education.
Abreu DV, Tamura TK, Sipp JA, Keamy DG Jr, Eavey RD. Abreu DV, et al. Ear Nose Throat J. 2008 Apr;87(4):208, 210-1. Ear Nose Throat J. 2008. PMID: 18478793
Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus Alum.
Dos-Santos JS, Firmino-Cruz L, da Fonseca-Martins AM, Oliveira-Maciel D, Perez GG, Roncaglia-Pereira VA, Dumard CH, Guedes-da-Silva FH, Santos ACV, Leandro MDS, Ferreira JRM, Guimarães-Pinto K, Conde L, Rodrigues DAS, Silva MVM, Alvim RGF, Lima TM, Marsili FF, Abreu DPB, Ferreira OC Jr, Mohana Borges RDS, Tanuri A, Souza TML, Rossi-Bergmann B, Vale AM, Silva JL, de Oliveira AC, Filardy AD, Gomes AMO, de Matos Guedes HL. Dos-Santos JS, et al. Among authors: abreu dpb. Front Immunol. 2022 Jun 30;13:884760. doi: 10.3389/fimmu.2022.884760. eCollection 2022. Front Immunol. 2022. PMID: 35844561 Free PMC article.
Antibody response and soluble mediator profile in the first six months following acute SARS-CoV-2 infection.
Corsini CA, Filgueiras PS, Almeida NB, Miranda DA, Gomes SV, Lourenço AJ, Bicalho CM, Assis JV, Amorim RN, Silva RA, Vilela RV, Lima TM, Abreu DP, Alvim RG, Castilho LR, Martins-Filho OA, Otta DA, Grenfell RF. Corsini CA, et al. Among authors: abreu dp. Sci Rep. 2023 Oct 30;13(1):18606. doi: 10.1038/s41598-023-43263-y. Sci Rep. 2023. PMID: 37903875 Free PMC article.
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.
Grenfell RFQ, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, Lourenço AJ, Martins-Filho OA, de Oliveira JG, Teixeira-Carvalho A, Campos GRF, Nogueira ML, Alves PA, Fernandes GR, Castilho LR, Lima TM, de Abreu DPB, Alvim RGF, Silva TBS, Jeremias WJ, Otta DA, Campi-Azevedo AC; Immunita-001 Team. Grenfell RFQ, et al. Among authors: de abreu dpb. Front Immunol. 2022 Jun 9;13:918896. doi: 10.3389/fimmu.2022.918896. eCollection 2022. Front Immunol. 2022. PMID: 35757764 Free PMC article. Clinical Trial.
18 results